An oncology pharmacist discusses how to prevent and treat the toxicities from regorafenib for the treatment of colorectal cancer.
Amber Draper, PharmD, BCOP
Advertisement
Articles by Amber Draper, PharmD, BCOP
Advertisement
Latest Updated Articles
Regorafenib for Metastatic Colorectal Cancer: Common Toxicities and Prevention StrategiesPublished: April 15th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
AI-Powered Scout Platform Could Enhance Oncology Decision-Making With Data- and Expert-Driven Insights
2
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
3
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
4
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
5
